Course Director

Agata Rembielak, Radiation Oncologist and Clinical Oncologist, The Christie Hospital and The University of Manchester, Manchester (UK)

Teachers

• Alessandro Di Stefani, Dermatologist and Dermatopathologist, Università Cattolica del Sacro Cuore, Rome (IT)

• Damir Kosutic, Plastic and Reconstructive Surgeon, The Christie Hospital, Manchester (UK)

• Anita O’Donovan, Radiographer with research interest in geriatric oncology, Trinity College, Dublin (IE)

• Susy Pramod, Tissue Viability Nurse, The Christie Hospital, Manchester (UK)

• Luca Tagliaferri, Radiation Oncologist, Fondazione Policlinico Universitario «Agostino Gemelli» IRCCS, Rome (IT)

• Anysja Zuchora, Medical Physicist, Galway University Hospital, Galway (IE)

Recently there has been an alarming increase in skin cancer incidence worldwide, particularly in NMSC. NMSC is the most common malignancy but its public significance is often unrecognised. Although mortality from NMSC is rare in the general population, treatment of NMSC is becoming a considerable burden for health care services across the world due to rapidly increasing number of new cases, aging population and increased complexity of cases, often requiring a specialist multidisciplinary approach. 

This course aims to:

• Provide a comprehensive overview of current management options in NMSC

• Highlight the need for improved interdisciplinary collaboration

The course will be interactive through integration of multidisciplinary lectures and more focused debates and case discussions. The faculty includes renowned experts involved in the multidisciplinary treatment of NMSC. It is hoped that the course will serve a vital reference for all professionals involved in the management of NMSC

Learning outcomes

By the end of this course participants should be able to:

• Understand prophylaxis, epidemiology and pathology of NMSC with special focus on basal, cutaneous squamous and Merkel cell carcinoma. Rare skin cancers will also be included.

• Discuss advantages and limitations of imaging modalities used for diagnosis and treatment of NMSC

• Understand indications and limitations of surgical and non-surgical treatment modalities in NMSC

• Design a radical and palliative radiotherapy plan for NMSC

• Develop a deep understanding of best practices in NMSC and provide patients with the best possible treatment, skin care advice and follow-up care

• Understand challenges of palliative and supportive care in NMSC patients

• Have a general understanding of principles in geriatric oncology and integrate geriatric oncology assessment into clinical practice patients with NMSC

• Summarise the latest developments and gain knowledge of future directions in research and clinical trials in the management of NMSC.

Course content

• Epidemiology, prevention and pathology of NMSC
• The role of imaging in diagnosis and treatment of NMSC
• Surgical and non-surgical treatments of NMSC
• Physics and mould room input in dermatological radiotherapy and brachytherapy
• Radiobiology of the skin and re-irradiation
• Follow-up and management of side effects during and after skin cancer treatment
• Role of allied health care professionals in NMSC management
• Concept and management of high risk, locally advanced and metastatic NMSC
• NMSC in special circumstances and rare skin pathologies
• Role of multidisciplinary team meetings in the management of NMSC
• Overview of current research, clinical trials and technical developments in the management of NMSC
• Quality of life and geriatric assessment in skin oncology

Prerequisites

Before commencing this course participants should:

• Revise anatomy and histology of the skin and lymphatic system with common drainage routes
• Have at least basic knowledge of main NMSC types and their clinical presentation
• Have at least basic knowledge of standard surgical and non-surgical treatment modalities in NMSC
• Have at least basic experience with radiation therapy in patients with NMSC. If the participant is not a radiation oncologist or clinical oncologist (including training post) they should be involved in multidisciplinary case discussions or have special interest in the management of patients with NMSC
• Be prepared to ask questions and contribute to live and interactive discussions
• Ensure you have watched mandatory pre-course material.

Teaching methods

The course is delivered virtually over two days and will include:

•  Prerequisite course materials
•  Didactic lectures
•  Debates and case discussions

Students will be advised to review the prerequisite course materials and suggested readings on ESTRO Moodle before the course. The prerequisite materials and virtual sessions create a complete subject unit.

Methods of assessment

• Multiple choice questions (MCQ)
• Mark-out exercises
• Evaluation form

Key words

Non-melanoma skin cancer, multimodality management, surgery, radiotherapy, systemic treatment, high risk non-melanoma skin cancer, volume delineation, side effects, cosmesis, quality of life, geriatric assessment.

To follow

Membership

ESTRO members can order products at substantially reduced prices. To benefit from the member registration rate, you must subscribe for the ESTRO membership 2022 BEFORE registering to the course. To become an ESTRO member, benefit from the member registration rate and discover the many other member advantages, please visit the membership page.

Fees

* Members with specialty RadiationTherapist (RTT) may register at the In-Training fee

The standard rate is applied until the early rate published on the front webpage of this course expires.

Desk rates are applied after the early rate published on the front webpage of this course expires.

Advance registration & payment are required.              

Registration will close on the date published on the front page of the course.
 

Cancellation

A registration to the online workshop may be cancelled without any fees before pre-online course material is sent out. Pre-online course material is sent out a few days before the first workshop lesson. After the pre-online course material is sent out, no refund of the registration fee is possible.

Reduced fees

Members from emerging countries may register at a preferential rate of 350 Euro. Emerging country fee applies to individuals from low-income and lower-middle-income economies according to the World Bank listing here.

Additionally, all specialties from the following countries can benefit from this preferential rate: Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Poland, Portugal, Romania, Russian Federation, Serbia, Slovak Republic, Slovenia, Spain, Turkey, Ukraine.  In addition, medical physicists from Cyprus can email education@estro.org to apply for this fee.

The preferential rate of 350 Euro is granted automatically when you click on the  BOOK NOW  button and the three conditions below are met:

1. Only ESTRO members for 2022 are eligible (please make sure your 2022 membership is in order before you click on the BOOK NOW  button)
2. Only one course per person per year can be subsidized by ESTRO
3. Sponsored candidates are not entitled to reduced fees (the invoicing address has to be the one of the participant)  

 Please note:

• We can only guarantee a certain number of reduced fees per course
• Application deadlines are the same as early registration fees (3 months before the course date).